Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$977M |
| 2 |
Verizon
VZ
|
+$429M |
| 3 |
AstraZeneca
AZN
|
+$420M |
| 4 |
Texas Instruments
TXN
|
+$420M |
| 5 |
General Dynamics
GD
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$863M |
| 2 |
Electronic Arts
EA
|
+$765M |
| 3 |
Eaton
ETN
|
+$556M |
| 4 |
Meta Platforms (Facebook)
META
|
+$535M |
| 5 |
Applied Materials
AMAT
|
+$534M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Financials | 11.45% |
| 3 | Healthcare | 7.98% |
| 4 | Industrials | 7.85% |
| 5 | Consumer Discretionary | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Southern California Bancorp
BCAL
$684M
| $1.15M | ﹤0.01% |
+61,825
| New | +$1.14M |
|
|
ONC
3227
BeOne Medicines Ltd
ONC
$32.8B
| $1.15M | ﹤0.01% |
3,798
+958
| +34% | +$314K |
|
3228
ORIX
IX
$44B
| $1.15M | ﹤0.01% |
39,409
-681
| -2% | -$18K |
|
3229
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$849M
| $1.15M | ﹤0.01% |
46,011
-45
| -0.1% | -$1.12K |
|
3230
Monro
MNRO
$383M
| $1.15M | ﹤0.01% |
57,153
-58,458
| -51% | -$1.08M |
|
|
FTMH
3231
Franklin Municipal High Yield ETF
FTMH
$584M
| $1.14M | ﹤0.01% |
+98,903
| New | +$1.15M |
|
3232
TC Energy
TRP
$70.2B
| $1.14M | ﹤0.01% |
18,722
-1,081
| -5% | -$57.7K |
|
3233
Fulcrum Therapeutics
FULC
$239M
| $1.14M | ﹤0.01% |
100,675
-23,991
| -19% | -$244K |
|
|
TEM
3234
Tempus AI
TEM
$7.9B
| $1.14M | ﹤0.01% |
21,382
-3,570
| -14% | -$279K |
|
3235
TriMas Corp
TRS
$1.43B
| $1.13M | ﹤0.01% |
31,913
+1,511
| +5% | +$52.8K |
|
3236
1st Source
SRCE
$2.16B
| $1.13M | ﹤0.01% |
18,091
-136
| -0.7% | -$8.41K |
|
3237
iBio
IBIO
$69.5M
| $1.13M | ﹤0.01% |
584,368
+102,068
| +21% | +$139K |
|
3238
Xeris Biopharma Holdings
XERS
$1.39B
| $1.13M | ﹤0.01% |
143,463
-10,705
| -7% | -$84.3K |
|
3239
Washington Trust Bancorp
WASH
$743M
| $1.12M | ﹤0.01% |
37,880
| – | – |
|
3240
iShares Global Equity Factor ETF
GLOF
$216M
| $1.11M | ﹤0.01% |
20,983
-1,110
| -5% | -$58K |
|
3241
Corbus Pharmaceuticals
CRBP
$166M
| $1.1M | ﹤0.01% |
135,730
+66,105
| +95% | +$816K |
|
|
BIOA
3242
BioAge Labs
BIOA
$402M
| $1.1M | ﹤0.01% |
82,963
+52,500
| +172% | +$465K |
|
|
CCD
3243
Calamos Dynamic Convertible & Income Fund
CCD
$707M
| $1.09M | ﹤0.01% |
52,460
+4,913
| +10% | +$105K |
|
3244
Ooma
OOMA
$598M
| $1.09M | ﹤0.01% |
93,099
-521
| -0.6% | -$5.94K |
|
|
DENN
3245
DELISTED
Denny's
DENN
| $1.09M | ﹤0.01% |
175,437
-1,060
| -0.6% | -$6.01K |
|
3246
Gold Fields
GFI
$29B
| $1.09M | ﹤0.01% |
24,967
+510
| +2% | +$21.3K |
|
3247
M-tron Industries
MPTI
$356M
| $1.08M | ﹤0.01% |
20,376
-859
| -4% | -$45.4K |
|
3248
Flotek Industries
FTK
$852M
| $1.08M | ﹤0.01% |
62,922
+45,600
| +263% | +$724K |
|
3249
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.26B
| $1.08M | ﹤0.01% |
50,518
-2,297
| -4% | -$48.9K |
|
|
AHL
3250
DELISTED
Aspen Insurance
AHL
| $1.07M | ﹤0.01% |
28,945
-8,355
| -22% | -$308K |
|
Similar funds
Ameriprise's Q4 2025 Portfolio in Review
As of Q4 2025, Ameriprise held 4,249 positions worth $443B, up 1.6% from $435B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2025 filing shows 211 new, 1,747 increased, 1,995 reduced and 178 closed positions. Its largest new stake was NexGen Energy: 8,483,607 shares worth $78M. The largest sale was Alphabet (Google) Class A, an estimated $863M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2025 buy was NexGen Energy: 8,483,607 shares worth $78M.
- Ameriprise added most to Salesforce in Q4 2025, an estimated $977M increase.
- Ameriprise's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $863M.
- Ameriprise fully exited Merus in Q4 2025, selling an estimated $84.6M.
- Ameriprise's ten largest holdings make up 21% of its $443B portfolio in Q4 2025.
- Ameriprise opened 211 new positions and closed 178 in Q4 2025.
- Ameriprise's portfolio value rose 1.6% quarter-over-quarter to $443B.
Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.